Delivering phase-appropriate formulations to support preclinical and early-phase clinical evaluation.
Arcinova have a proven track record in developing a wide range of drug product formats across oral, inhaled, and parenteral routes. Whether you’re optimising an early concept or refining your FIH formulation, we apply a data-driven, phase-appropriate approach that ensures speed, scalability and regulatory compliance.
Our highly skilled team tailors each solution to your molecule’s physicochemical and biopharmaceutic profile, intended route of administration, and stage of development.
With over 40 years of drug product formulation development and manufacturing experience, we bring science-driven agility to help you move forward, faster.
40+ year formulation development & manufacturing experience
Purpose built 48,000ft2 drug product facility
Experienced formulation, development and manufacturing teams
Over 1,500 formulations developed
Arcinova: Science-driven agility to help you move forward, faster.
With over four decades of experience and fully integrated teams across formulation, analytical and manufacturing science, we deliver phase-appropriate drug products that help you reach the clinic faster.